Vitalik Buterin: Hopes developers can express their performance in terms of ratios rather than "N operations per second"
Jinse Finance reported that Vitalik Buterin posted on X, stating, "I hope more ZK and FHE developers can express their performance in terms of ratio (encrypted computation time vs. raw computation time), that is, 'time required for encrypted computation / time required for raw computation,' rather than simply saying 'we can do N operations per second.' This approach is more hardware-independent and provides a very valuable metric: how much efficiency am I sacrificing to enable encryption/privacy features for my application, instead of relying on trust mechanisms? This method is also generally more useful for estimation, because as a developer, I already know roughly how long the raw computation takes, so I just need to multiply by this ratio to estimate the overhead of encryption."
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Hypertension drug developer Retension (RTSN.US) applies for US listing, plans to raise $58 million.
U.S. hypertension drug developer Retension Pharmaceuticals filed documents with the SEC last Friday, planning to raise up to $58 million through an initial public offering (IPO).
Pfizer (PFE.US) overseas price increase gains to be shared with the U.S. government: "Most Favored Nation" contract revealed, over twenty transactions still confidential
According to reports, under a new contract with the U.S. Department of Health and Human Services, Pfizer will share higher overseas drug revenues with the United States.
Autoimmune and inflammatory disease pharmaceutical company TRex Bio (TRX.US) applies for US listing, plans to raise up to 100 millions dollars.
TRex Bio filed documents with the U.S. Securities and Exchange Commission (SEC) last Friday, intending to raise up to 100 million USD through an initial public offering (IPO).
